PCGF6 Human Pre-designed siRNA Set A contains three designed siRNAs for PCGF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCID2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCID2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCIF1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCIF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCK1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCK2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCLAF Human Pre-designed siRNA Set A contains three designed siRNAs for PCLAF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCLO Human Pre-designed siRNA Set A contains three designed siRNAs for PCLO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCMTD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCMTD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCNA Human Pre-designed siRNA Set A contains three designed siRNAs for PCNA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCNP Human Pre-designed siRNA Set A contains three designed siRNAs for PCNP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCNT Human Pre-designed siRNA Set A contains three designed siRNAs for PCNT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCNX2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCNX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCOLCE Human Pre-designed siRNA Set A contains three designed siRNAs for PCOLCE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pcolce Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pcolce gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Pcolce Rat Pre-designed siRNA Set A contains three designed siRNAs for Pcolce gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCOLCE2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCOLCE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCP2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCP4 Human Pre-designed siRNA Set A contains three designed siRNAs for PCP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCP4L1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCP4L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK1N Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK1N gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK4 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK5 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK6 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK7 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK9 Human Pre-designed siRNA Set A contains three designed siRNAs for PCSK9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCSK9-IN-26 (Compound 116) is an PCSK9 inhibitor (IC50 < 1 nM). PCSK9-IN-26 can be used for metabolic research[1].

PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM). PCSK9-IN-27 reduces LDLR degradation and increases LDL-C uptake[1].

PCTP Human Pre-designed siRNA Set A contains three designed siRNAs for PCTP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCTR2 is a protectin sulfidoconjugate, which is a pro-resolving mediator that exhibits activity towards inflammation and tissue regeneration[1].

PCTR3 is a Docosahexaenoic acid DHA (HY-B2167) derivative, which acts as a pro-resolving and tissue regeneration lipid mediator[1].

PCYOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for PCYOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCYT1A Human Pre-designed siRNA Set A contains three designed siRNAs for PCYT1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCYT1B Human Pre-designed siRNA Set A contains three designed siRNAs for PCYT1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PCYT2 Human Pre-designed siRNA Set A contains three designed siRNAs for PCYT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PD-1/PD-L1 antagonist 1 (Compound A5) is an antagonist for programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) interaction, with an IC50 of 23.78 nM[1].

PD-1/PD-L1-IN-39 (X 14) is an orally active PD-1/PD-L1 inhibitor with a IC50 value of 15.73 nM. PD-1/ PD-L1-in-39 has a good binding affinity for human and mouse PD-L1, with KD values of 14.62 nM and 392 nM, respectively. PD-1/PD-L1-IN-39 has antitumor activity[1].

PD-1/PD-L1-IN-40 (Compound EP16) is a PD-1/PD-L1 inhibitor. PD-1/PD-L1-IN-40 inhibits the generation of exosomal PD-L1 with IC50 = 0.108 μM. PD-1/PD-L1-IN-40 can serve as a leading compound for exosomal PD-L1 abrogation. PD-1/PD-L1-IN-40 can be used for the research of cancer[1].

PD-1/ PD-L1-in-41 (Compound 5c) is a PD-L1 and PD-1 inhibitor with IC50 value of 10.2 nM[1].

PD-1/PD-L1-IN-42 (Compound B8.4) is an inhibitor of the interaction between PD-1 and PD-L1, with an EC50 of 0.1 μM. PD-1/PD-L1-IN-42 can be used for the research of cancer immunotherapy[1].

PD-1/PD-L1-IN-43 (compound Z13) is a small-molecule inhibitors targeting the PD-1/PD-L1 interaction. PD-1/PD-L1-IN-43 exhibites potent in vivo antitumor efficacy against B16-F10 melanoma. PD-1/PD-L1-IN-43 inhibits tumor growth by blocking the interaction between PD-1 and PD-L1. PD-1/PD-L1-IN-43 can be used in anti-tumor studies[1].